Atyr Pharma Inc (ATYR)
followers
ยท
Follow
Sector: | HEALTH CARE |
Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
CEO: | Sanjay S. Shukla |
Employees: | 53 |
Web site: | atyrpharma.com |
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
8587318389
|
Date | Ratio |
---|---|
2019-07-01 | 1:14 |
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trials for treatment of other interstitial lung diseases (ILDs) The company was incorporated in 2005 and is headquartered in San Diego, California.
Please log in first to see chart